Terms: = Kidney tumors AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Prognosis
41 results:
1. [Analysis of prognosis and related factors in oldest-old patients with left-side or right-side colon cancer after hemicolectomy].
An Q; Shi JX; Cui J; Li ZJ; Ma FH; Xiao G; Jia WW; Tang DN; Zhao G; Wu GJ
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1666-1672. PubMed ID: 37302856
[No Abstract] [Full Text] [Related]
2. Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscle invasive bladder cancer in patients with solid organ transplant.
Simonet M; Dominguez Gutierrez A; Territo A; Prudhomme T; Campi R; Andras I; Baboudjian M; Hevia V; Boissier R;
World J Urol; 2022 Dec; 40(12):2901-2910. PubMed ID: 36367586
[TBL] [Abstract] [Full Text] [Related]
3. AIM2 upregulation promotes metastatic progression and PD-L1 expression in lung adenocarcinoma.
Zheng JQ; Lin CH; Lee HH; Chang WM; Li LJ; Su CY; Lee KY; Chiu HW; Lin YF
Cancer Sci; 2023 Jan; 114(1):306-320. PubMed ID: 36104978
[TBL] [Abstract] [Full Text] [Related]
4. [Correlation between metabolic syndrome and prognosis of patients with clear cell renal cell carcinoma].
Zuo MN; DU YQ; Yu LP; Dai X; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):636-643. PubMed ID: 35950385
[TBL] [Abstract] [Full Text] [Related]
5. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750
[No Abstract] [Full Text] [Related]
6. Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma.
Ishihara H; Tachibana H; Fukuda H; Yoshida K; Kobayashi H; Takagi T; Iizuka J; Ishida H; Kondo T; Tanabe K
Urol Int; 2022; 106(4):368-375. PubMed ID: 34515259
[TBL] [Abstract] [Full Text] [Related]
7. "Collecting duct carcinoma of the kidney: diagnosis and implications for management".
Cabanillas G; Montoya-Cerrillo D; Kryvenko ON; Pal SK; Arias-Stella JA
Urol Oncol; 2022 Dec; 40(12):525-536. PubMed ID: 34116936
[TBL] [Abstract] [Full Text] [Related]
8. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K; Williamson SR; Gill AJ; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Hes O
Mod Pathol; 2021 Jun; 34(6):1167-1184. PubMed ID: 33526874
[TBL] [Abstract] [Full Text] [Related]
9. High MCM6 Expression as a Potential Prognostic Marker in Clear-cell Renal Cell Carcinoma.
Jang NR; Baek J; Ko Y; Song PH; Gu MJ
In Vivo; 2021; 35(1):299-306. PubMed ID: 33402477
[TBL] [Abstract] [Full Text] [Related]
10. Population-based estimates of survival among elderly patients with brain metastases.
Lamba N; Kearney RB; Catalano PJ; Hassett MJ; Wen PY; Haas-Kogan DA; Aizer AA
Neuro Oncol; 2021 Apr; 23(4):661-676. PubMed ID: 33068418
[TBL] [Abstract] [Full Text] [Related]
11. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative
Wu C; Cui Y; Zhao Y; Chen X; Liao X; Di L; Yin L; Liu M; Wang R
Eur J Radiol; 2020 Oct; 131():109218. PubMed ID: 32882538
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy.
Shan H; Tian W; Hong Y; Xu B; Wang C; Yu B; Wang X
BMC Complement Med Ther; 2020 Jun; 20(1):166. PubMed ID: 32493345
[TBL] [Abstract] [Full Text] [Related]
13. Association of tumor grade, enhancement on multiphasic CT and microvessel density in patients with clear cell renal cell carcinoma.
Coy H; Young JR; Pantuck AJ; Douek ML; Sisk A; Magyar C; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2020 Oct; 45(10):3184-3192. PubMed ID: 31650375
[TBL] [Abstract] [Full Text] [Related]
14. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract] [Full Text] [Related]
15. Renal Medullary Carcinoma: a Report of the Current Literature.
Blas L; Roberti J; Petroni J; Reniero L; Cicora F
Curr Urol Rep; 2019 Jan; 20(1):4. PubMed ID: 30656488
[TBL] [Abstract] [Full Text] [Related]
16. First-line tyrosine kinase inhibitors in metastatic renal cell carcinoma: A regional cancer center experience.
Rudresha AH; Chaudhuri T; Lakshmaiah KC; Babu GK; Lokanatha D; Jacob LA; Suresh Babu MC; Lokesh KN; Rajeev LK
Indian J Cancer; 2017; 54(4):626-630. PubMed ID: 30082547
[TBL] [Abstract] [Full Text] [Related]
17. [Clinicopathologic features of primary mucosal CD30-positive T-cell lymphoproliferative disorders in head and neck region].
Liu F; Li M; Zhang LY; Guo L; Hu WW; Rao HL
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):412-416. PubMed ID: 29886583
[No Abstract] [Full Text] [Related]
18. Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy.
Lee H; Lee M; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BMC Cancer; 2018 Apr; 18(1):427. PubMed ID: 29661179
[TBL] [Abstract] [Full Text] [Related]
19. [Langerhans cell sarcoma: a clinicopathologic analysis of four cases].
Huang HJ; Chen XY; Zheng ZY
Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):163-167. PubMed ID: 29534353
[No Abstract] [Full Text] [Related]
20. Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules.
Kawashima A; Kanazawa T; Goto K; Matsumoto M; Morimoto-Okazawa A; Iwahori K; Ujike T; Nagahara A; Fujita K; Uemura M; Nonomura N; Wada H
Cancer Immunol Immunother; 2018 Jan; 67(1):113-125. PubMed ID: 28975380
[TBL] [Abstract] [Full Text] [Related]
[Next]
